By proceeding, you agree to our Terms of Use and Privacy Policy.
Proveris helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner, saving significant time and money.Proveris believes that developing effective OINDP products requires in-depth knowledge and expertise to understand and control the complex relationships among drug delivery devices, formulations, and human usage that drive product performance. Proveris believes that applying intelligent automation technology, modern data analysis, and proven experimentation techniques leads directly to superior product knowledge and to successful therapies reaching patients far sooner than possible any other way. For more than 20 years, Proveris has worked closely with pharmaceutical companies, device suppliers, contract development, research, and manufacturing organizations, and global regulatory agencies who believe in this focus to elevate the standards in the industry and deliver effective therapies.
17-18 May 2023
The COVID-19 pandemic has not only stimulated interest in new modalities research but also sparked a resurgence in formulation approaches among biopharmaceutical companies, leading to the development of a new wave of drug substances and therapeutics.
Event Ended
USA
Paid
San Diego
27-27 September 2023
The 14th Annual Arizona Technology Summit will be held on September 27th, 2023 at the Phoenix Convention Center (100 N 3rd Street, Phoenix, AZ 85004) from 8am-4pm. This B2B conference is targeted for the Technology and Security community. Attendees c
PHOENIX
02-03 October 2023
Over 300 attendees representing internationally renowned academic organisations & research institutes as well as global pharmaceutical organisations, leading biotech companiesOver 20 case studies, presentations, panel discussions focused on the k